Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 8658616

Nucleoside aryl phosphoramidates and their use as anti-viral agents for the treatment of h

University College Cardiff Consultants Limited · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653070

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8647637

Immunogenic compositions, vaccines and diagnostics based on canine distemper viruses circu

The Board of Regents for Oklahoma State University · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8632782

Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8623814

Antiviral agents

Enanta Pharmaceuticals, Inc. · Granted Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618270

Oligonucleotide analog and method for treating flavivirus infections

Sarepta Therapeutics, Inc. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614082

Attenuation of encephalitogenic alphavirus and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8613934

Cellular and viral inactivation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609648

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609404

Vaccines containing canine parvovirus genetic variants

The Board of Regents for Oklahoma State University · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592570

Compositions and methods for inhibiting expression of an RNA from West Nile virus

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8568739

Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8551965

Anti-viral pyrimidine nucleoside analogues

University College Cardiff Consultants Limited · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8541221

Primate T-lymphotropic viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524676

Method for treating enterovirus or rhinovirus infection using antisense antiviral compound

Sarepta Therapeutics, Inc. · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524247

Rabies virus-based recombinant immunocontraceptive compositions and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8524248

Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Sep 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 29 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8513005

DNA immunogenic composition comprising a full-length modified poxvirus L1R gene fused to a

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8512712

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8506947

Vaccinia virus expression vector for selective replication in a tumor cell and introductio

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8506961

Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8507522

Hepatitis C virus inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Aug 13 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 08 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501194

Vaccine for viruses that cause persistent or latent infections

The Regents of the University of California · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8501681

Macrocyclic hepatitis C virus serine protease inhibitors

Enanta Pharmaceuticals, Inc. · Granted Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted